Emergence of red blood cell alloantibodies and transfusion management in patients with warm autoantibodies at a tertiary care centre in British Columbia, Canada
Vox Sanguinis · 2026
DOI: 10.1111/vox.70177 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Vox Sanguinis, 2026. Verfasst von S Hutspardol und 8 weiteren Autor:innen. Beteiligte Einrichtung: Transfusion Medicine Laboratory, Vancouver Coastal Health Authority, Vancouver, British Columbia, Canada. Hauptthemen laut MEDLINE: Isoantibodies, Autoantibodies, Erythrocytes, Erythrocyte Transfusion. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background and Objectives The presence of warm autoantibodies (WAAs) complicates pre‐transfusion and compatibility testing. Despite attempts to provide antigen‐matched red blood cells (RBCs), the risk of alloimmunization remains. Rates of alloimmunization and indications for transfusion were reviewed to streamline testing and RBC provision algorithms at a large tertiary care centre serving patients with lymphoid cancers and complex surgical needs. Materials and Methods This retrospective observational study investigated the development of new RBC alloantibodies in patients with WAAs. This included 295,109 antibody screenings and 3129 antibody investigations (AIs) performed on 2493 patients between 1 September 2019 and 30 June 2024. AI results for patients with a history of WAAs were reviewed, along with diagnoses, transfusion data, and where applicable, phenotyping and genotyping results.
Results
Ninety‐four patients had WAAs. Twenty‐three of them (24%) had lymphoproliferative disorders (LPDs) and 21 (22%) required urgent antibody tests for surgical procedures. Fifty‐one patients (54%) received RBC transfusions, and 30 of them (59%) had anaemia with haemoglobin below 70 g/dL. Thirteen patients (14%) required RBC genotyping because of recent transfusions or indeterminate results. The alloimmunization rate was 10%, including anti‐Jk a , anti‐Kp a , anti‐Jk b , anti‐C w , anti‐Js a and anti‐Le a , after RHDCE/K or more extended‐matched RBC transfusions.
Conclusion
RBC alloantibodies develop in patients with WAAs, as the urgency of transfusions often limits the complete identification of antibodies and extended phenotype matching. With prompt investigation and RBC preparation, the risk of alloimmunization to major antibodies can be minimized.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Transfusion Medicine Laboratory, Vancouver Coastal Health Authority, Vancouver, British Columbia, Canada.
- Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
- Medical Affairs and Innovation, Canadian Blood Services, Ottawa, Ontario, Canada.
ORCID-Profile: S Hutspardol
Zitieren
APA
Hutspardol, S., Mi, J., Denesiuk, C., Kalar, D., Sham, L., Roche, M., Tsu, J. R., Lam, D., & Yan, M. T. S. (2026). Emergence of red blood cell alloantibodies and transfusion management in patients with warm autoantibodies at a tertiary care centre in British Columbia, Canada. Vox Sanguinis. https://doi.org/10.1111/vox.70177
Vancouver
Hutspardol S, Mi J, Denesiuk C, Kalar D, Sham L, Roche M, et al. Emergence of red blood cell alloantibodies and transfusion management in patients with warm autoantibodies at a tertiary care centre in British Columbia, Canada. Vox Sanguinis. 2026. doi:10.1111/vox.70177
BibTeX
@article{Hutspardol2026,
author = {Hutspardol, S and Mi, J and Denesiuk, C and Kalar, D and Sham, L and Roche, M and Tsu, J R and Lam, D and Yan, M T S},
title = {Emergence of red blood cell alloantibodies and transfusion management in patients with warm autoantibodies at a tertiary care centre in British Columbia, Canada},
journal = {Vox Sanguinis},
year = {2026},
doi = {10.1111/vox.70177}
}
EUVIMED